Quon H - Search Results

1

Risk factors for early-onset group B streptococcal disease in neonates: a population-based case-control study.

Adair CE, Kowalsky L, Quon H, Ma D, Stoffman J, McGeer A, Robertson S, Mucenski M, Davies HD. Adair CE, et al. Among authors: quon h. CMAJ. 2003 Aug 5;169(3):198-203. CMAJ. 2003. PMID: 12900477 Free PMC article.

2

Active treatment in low-risk prostate cancer: a population-based study.

Roy S, Hyndman ME, Danielson B, Fairey A, Lee-Ying R, Cheung WY, Afzal AR, Xu Y, Abedin T, Quon HC. Roy S, et al. Among authors: quon hc. Curr Oncol. 2019 Aug;26(4):e535-e540. doi: 10.3747/co.26.4953. Epub 2019 Aug 1. Curr Oncol. 2019. PMID: 31548822 Free PMC article.

3

Application of machine learning methodology for PET-based definition of lung cancer.

Kerhet A, Small C, Quon H, Riauka T, Schrader L, Greiner R, Yee D, McEwan A, Roa W. Kerhet A, et al. Among authors: quon h. Curr Oncol. 2010 Feb;17(1):41-7. doi: 10.3747/co.v17i1.394. Curr Oncol. 2010. PMID: 20179802 Free PMC article.

4

Androgen deprivation therapy for prostate cancer-review of indications in 2010.

Quon H, Loblaw DA. Quon H, et al. Curr Oncol. 2010 Sep;17 Suppl 2(Suppl 2):S38-44. doi: 10.3747/co.v17i0.698. Curr Oncol. 2010. PMID: 20882131 Free PMC article.

5

Hypofractionated concomitant intensity-modulated radiotherapy boost for high-risk prostate cancer: late toxicity.

Quon H, Cheung PC, Loblaw DA, Morton G, Pang G, Szumacher E, Danjoux C, Choo R, Thomas G, Kiss A, Mamedov A, Deabreu A. Quon H, et al. Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):898-905. doi: 10.1016/j.ijrobp.2010.11.003. Epub 2011 Jan 14. Int J Radiat Oncol Biol Phys. 2012. PMID: 21237581 Clinical Trial.

6

Dramatic increase in prostate cancer cases by 2021.

Quon H, Loblaw A, Nam R. Quon H, et al. BJU Int. 2011 Dec;108(11):1734-8. doi: 10.1111/j.1464-410X.2011.10197.x. Epub 2011 Apr 20. BJU Int. 2011. PMID: 21507185

7

Quality of life after hypofractionated concomitant intensity-modulated radiotherapy boost for high-risk prostate cancer.

Quon H, Cheung PC, Loblaw DA, Morton G, Pang G, Szumacher E, Danjoux C, Choo R, Kiss A, Mamedov A, Deabreu A. Quon H, et al. Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):617-23. doi: 10.1016/j.ijrobp.2011.07.005. Epub 2011 Nov 11. Int J Radiat Oncol Biol Phys. 2012. PMID: 22079736 Clinical Trial.

8

Dynamics of three-dimensional telomere profiles of circulating tumor cells in patients with high-risk prostate cancer who are undergoing androgen deprivation and radiation therapies.

Wark L, Klonisch T, Awe J, LeClerc C, Dyck B, Quon H, Mai S. Wark L, et al. Among authors: quon h. Urol Oncol. 2017 Mar;35(3):112.e1-112.e11. doi: 10.1016/j.urolonc.2016.10.018. Epub 2016 Dec 10. Urol Oncol. 2017. PMID: 27956006 Free article.

9

Stereotactic ablative radiotherapy in the treatment of low and intermediate risk prostate cancer: Is there an optimal dose?

Helou J, D'Alimonte L, Quon H, Deabreu A, Commisso K, Cheung P, Chu W, Mamedov A, Davidson M, Ravi A, Loblaw A. Helou J, et al. Among authors: quon h. Radiother Oncol. 2017 Jun;123(3):478-482. doi: 10.1016/j.radonc.2017.03.006. Epub 2017 Apr 19. Radiother Oncol. 2017. PMID: 28433413

10

Dose escalation for prostate stereotactic ablative radiotherapy (SABR): Late outcomes from two prospective clinical trials.

Alayed Y, Cheung P, Pang G, Mamedov A, D'Alimonte L, Deabreu A, Commisso K, Commisso A, Zhang L, Quon HC, Musunuru HB, Helou J, Loblaw DA. Alayed Y, et al. Radiother Oncol. 2018 May;127(2):213-218. doi: 10.1016/j.radonc.2018.03.005. Epub 2018 Mar 24. Radiother Oncol. 2018. PMID: 29588072 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

234 results

Search Page

Filters